FDA Inspection
Exquisite CorporationExquisite Corporation – FDA Inspection, Apr 26, 2023
Record Details
This FDA Inspection record concerns Exquisite Corporation, with an inspection on April 26, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a92c52f0-0158-42ec-8881-84dd088a3415
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1205627
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Exquisite Corporation
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 9, 2013 | NAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
Other documents for Exquisite Corporation
- FDA Inspection 1245264 - 2024-08-01
- FDA Inspection 815499 - 2013-01-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.